EGFR, KRAS, BRAF-mutations and microsatellite instability are absent in goblet cell carcinoids of the appendix

McGory, 2005, Malignancies of the appendix: beyond case series reports, Dis Colon Rectum, 48, 2264, 10.1007/s10350-005-0196-4 Roy, 2010, Goblet cell carcinoid tumors of the appendix: an overview, World J Gastrointest Oncol, 2, 251, 10.4251/wjgo.v2.i6.251 Plockinger, 2008, Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinoma, Neuroendocrinology, 87, 20, 10.1159/000109876 Tang, 2010, Epithelial neoplasms of the appendix, Arch Pathol Lab Med, 134, 1612, 10.5858/2010-0073-CCR.1 Deschamps, 2010, Endocrine tumors of the appendix: a pathologic review, Arch Pathol Lab Med, 134, 871, 10.5858/134.6.871 van Eeden, 2007, Goblet cell carcinoid of the appendix: a specific type of carcinoma, Histopathology, 51, 763, 10.1111/j.1365-2559.2007.02883.x Tang, 2008, Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix, Am J Surg Pathol, 32, 1429, 10.1097/PAS.0b013e31817f1816 Heinemann, 2009, Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR, Cancer Treat Rev, 35, 262, 10.1016/j.ctrv.2008.11.005 Stancu, 2003, Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors, Mod Pathol, 16, 1189, 10.1097/01.MP.0000097362.10330.B1 Ramnani, 1999, K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix, Cancer, 86, 14, 10.1002/(SICI)1097-0142(19990701)86:1<14::AID-CNCR4>3.0.CO;2-X Barber, 2004, Somatic mutations of EGFR in colorectal cancers and glioblastomas, N Engl J Med, 351, 2883, 10.1056/NEJM200412303512724 Nagahara, 2005, Somatic mutations of epidermal growth factor receptor in colorectal carcinoma, Clin Cancer Res, 11, 1368, 10.1158/1078-0432.CCR-04-1894 Iyoda, 2011, Expression profiling and identification of potential molecular targets for therapy in pulmonary large-cell neuroendocrine carcinoma, Exp Ther Med, 2, 1041, 10.3892/etm.2011.343 Tsiatis, 2010, Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications, J Mol Diagn, 12, 425, 10.2353/jmoldx.2010.090188 Gao, 2010, Comparative analysis of dideoxy sequencing, the KRAS StripAssay and pyrosequencing for detection of KRAS mutation, World J Gastroenterol, 16, 4858, 10.3748/wjg.v16.i38.4858 Shia, 2008, Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry, J Mol Diagn, 10, 293, 10.2353/jmoldx.2008.080031 Gospodarowicz, 2010 Holt, 2013, Goblet cell carcinoids of the appendix, Sci World J, 2013, 543696, 10.1155/2013/543696 Neumann, 2009, Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer, Pathol Res Pract, 205, 858, 10.1016/j.prp.2009.07.010 Jass, 2007, Classification of colorectal cancer based on correlation of clinical, morphological and molecular features, Histopathology, 50, 113, 10.1111/j.1365-2559.2006.02549.x Safaee Ardekani, 2012, The prognostic value of BRAF mutation in colorectal cancer and melanoma: a systematic review and meta-analysis, PLoS ONE, 7, e47054, 10.1371/journal.pone.0047054 Pai, 2012, BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features, Am J Surg Pathol, 36, 744, 10.1097/PAS.0b013e31824430d7 Vilar, 2010, Microsatellite instability in colorectal cancer-the stable evidence, Nat Rev Clin Oncol, 7, 153, 10.1038/nrclinonc.2009.237 Yantiss, 2007, A comprehensive study of nondysplastic and dysplastic serrated polyps of the vermiform appendix, Am J Surg Pathol, 31, 1742, 10.1097/PAS.0b013e31806bee6d Zauber, 2011, Ki-ras gene mutations are invariably present in low-grade mucinous tumors of the vermiform appendix, Scand J Gastroenterol, 46, 869, 10.3109/00365521.2011.565070 Taggart, 2013, High-level microsatellite instability in appendiceal carcinomas, Am J Surg Pathol, 37, 1192, 10.1097/PAS.0b013e318282649b Rosell, 2009, Spanish lung cancer, screening for epidermal growth factor receptor mutations in lung cancer, N Engl J Med, 361, 958, 10.1056/NEJMoa0904554 De Pas, 2011, Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gefitinib, J Clin Oncol, 29, e819, 10.1200/JCO.2011.36.2251 Karkouche, 2012, Colorectal neuroendocrine carcinomas and adenocarcinomas share oncogenic pathways. A clinico-pathologic study of 12 cases, Eur J Gastroenterol Hepatol, 24, 1430, 10.1097/MEG.0b013e3283583c87 Tannapfel, 2005, BRAF gene mutations are rare events in gastroenteropancreatic neuroendocrine tumors, Am J Clin Pathol, 123, 256, 10.1309/YQBR9C05RU4DD3RN Gilbert, 2010, Molecular markers for novel therapies in neuroendocrine (carcinoid) tumors, Endocr Relat Cancer, 17, 623, 10.1677/ERC-09-0318 Yachida, 2012, Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors, Am J Surg Pathol, 36, 173, 10.1097/PAS.0b013e3182417d36 Perren, 2004, BRAF and endocrine tumors: mutations are frequent in papillary thyroid carcinomas, rare in endocrine tumors of the gastrointestinal tract and not detected in other endocrine tumors, Endocr Relat Cancer, 11, 855, 10.1677/erc.1.00841 Wang, 2005, Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors, Mod Pathol, 18, 1079, 10.1038/modpathol.3800389 Arnold, 2007, Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system, Int J Cancer, 120, 2157, 10.1002/ijc.22569